FDA details policy on facility reclassification requests under GDUFA III
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesChemistry, Manufacturing and Controls (CMC)ComplianceNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy